LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
35 funds hold it · Insiders net selling
Net selling: insiders sold $996.4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 4, 2026
Financial period
Third Quarter 2026
Earnings per share
$0.35 expected
Revenue
$7.72B expected
Estimates as of Nov 10, 2026
EPS expected
$0.31 to $0.44
Revenue expected
18 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 26, 2026Reported Nov 4, 2026 | $0.44est. $0.35 | +26.67%beat | $7.86Best. $7.72B+1.75% | +10.4%from $7.12B |
| Jun 27, 2026Reported Aug 5, 2026 | $0.50est. $0.32 | +55.76%beat | $7.68Best. $7.51B+2.32% | +11.6%from $6.89B |
| Mar 28, 2026Reported May 6, 2026 | $0.33est. $0.29 | +12.18%beat | $7.35BSEC filing | +10.7%from $6.64B |
| Dec 31, 2025Reported Feb 25, 2026 | $0.31est. $0.24 | +30.04%beat | $7.79BAlpha Vantage | No year-ago quarter |
| Sep 27, 2025Reported Dec 3, 2025 | $0.31Reported | No estimate | $7.12BSEC filing | No year-ago quarter |
| Jun 28, 2025Reported Aug 5, 2026 | Not on file | No estimate | $6.89BSEC filing | No year-ago quarter |
| Mar 29, 2025Reported May 6, 2026 | Not on file | No estimate | $6.64BSEC filing | No year-ago quarter |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $7.79B | $7.35B | $7.68B | $7.86B |
| Cost of what it sold | $5.87B | $5.69B | $5.47B | $5.93B |
| Gross profit | $1.91B | $1.67B | $2.21B | $1.93B |
| What it spent | ||||
| Sales and admin | $1.26B | $1.23B | $1.29B | $1.26B |
| Other operating costs | $224.0M | $15.0M | $525.0M | $166.0M |
| Total operating expenses | $1.49B | $1.24B | $1.82B | $1.43B |
| What was left | ||||
| Operating profit | $425.0M | $422.0M | $395.0M | $500.0M |
| Interest on debt | $166.0M | $165.0M | $168.0M | $165.0M |
| Profit before tax | $206.0M | $291.0M | $235.0M | $386.0M |
| Tax | $26.0M | $52.0M | $96.0M | $68.0M |
| Net profit | $180.0M | $129.0M | $60.0M | $195.0M |
| EBITDA | $467.0M | $681.0M | $659.0M | $810.0M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Sales rise to $7.86B at Medline (MDLN), but Q3 net income moves the other way.
NeutralNov 5GIC Reports 13.03% Ownership Stake in Medline Inc. Class A Shares
Leans bullishOct 3035 macro signals shaping MDLN right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
